Examining Cancer Research and DCA. If a promising cancer drug can’t get a patent, it risks never being used on a patient. Dr. Akbar Khan and Dr. Humaira Khan from Medicor Cancer Centres in Toronto. Broadcast and recorded at ThatChannel.com (http://www.thatchannel.com) 2010-05m-19 Check our site for the 24/7 live stream and so much more! http://thatchannel.com
A theoretical protocol for Cancer. This video examines DCA and Avemar to newer anti cancer agents, and suggests why they should work perfectly together to effect a broad based cure for many cancers.
Yes, I mispronounce apoptosis.
For more information, please visit:
Update! It's done, Venlafaxine is done! The proof https://www.martincwiner.com/scientific-consensus-reached-venlafaxine-opioid/. That's the biochemical 'mic drop'.
Mice Research quoted:
Venlafaxine is Naloxone ('anti-opioid') Reversible: